Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Cardiovascular"

424 News Found

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
Clinical Trials | April 24, 2026

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens

The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c


Global warming threatens health, environment and economic stability: Dr Jitendra Singh
Public Health | April 21, 2026

Global warming threatens health, environment and economic stability: Dr Jitendra Singh

The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder


Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online
Healthcare | April 21, 2026

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online

This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message


AstraZeneca backs next-gen cardiologists with India Coronary Conquest 2026
Healthcare | April 21, 2026

AstraZeneca backs next-gen cardiologists with India Coronary Conquest 2026

The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country


Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


Experts endorse low-sodium salt substitutes to cut India’s hypertension burden
Public Health | April 18, 2026

Experts endorse low-sodium salt substitutes to cut India’s hypertension burden

Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy


DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
Supply Chain | April 17, 2026

DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia

The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease